Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Smoking cessation
- Slaying the zombie concepts
- Stroke
- Tobacco addiction
- Tobacco addiction & stroke
- The more you smoke the more you stroke
- Second-hand smoke
- Relationship between smoking & stroke
- Stroke statistics
- INTERHEART: odds of MI & smoking rate
- Smoking outweighs blood pressure control
- Smoking diminishes benefits of statins
- Smoking is a “Habit”
- Probability of dependence for substances
- The cigarette - a drug delivery device
- Intra-arterial drug use
- Nicotine effect on the CNS
- A day in the life of blood nicotine
- Caffeine intake
- Smokers are not villains
- Smokers don’t require more information
- Clinician’s advice
- Pharmacotherapy
- Nicotine replacement therapy (NRT)
- Therapeutic gap of NRTs
- A smoke-free future
- As much as it takes for as long as it takes
- Standard orders
- Using NRT in CVD patients
- NRT and cardiovascular (CV) risk
- Bupropion
- Biology of nicotine addiction
- Contraindications
- Side effects
- NRT vs. Bupropion SR for smoking cessation
- New medications and approaches
- Effects of nicotine on the CNS
- CO-confirmed continuous abstinence
- Clinical leadership
- Keep calm and be systematic
- Cessation and the hospital
- Ottawa model for smoking cessation
- The Ottawa model - overview
- Smoking is a leading cause of hospitalization
- The Ottawa model - results
- The Ottawa model - results in 2-years
- Smoking cessation in clinical practice
- Important note
- Systematic approaches to smoking cessation
- Transforming care, behavior & practices
- Thank you
Topics Covered
- Smoking cessation in clinical practice
- Preconceptions about smoking
- Tobacco addiction & stroke statistics in smokers
- Second-hand smoke
- Smoking effect blood pressure control and statin use
- The cigarette as a drug delivery device
- Nicotine levels in blood
- Nicotine effect on the CNS
- Caffeine intake altered by cessation
- Nicotine replacement therapy (NRT) and its use in CVD patients
- Bupropion compared to NRT
- New medications and approaches
- Ottawa model for smoking cessation
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Pipe, A. (2018, December 31). Smoking & stroke: best practices for your patients [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/RKWD1577.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Andrew Pipe has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Stroke Prevention
Transcript
Please wait while the transcript is being prepared...
0:00
Good morning, I'm Andrew Pipe from
the Minto Prevention and Rehabilitation Center at
the University of Ottawa Heart Institute in Ottawa, Canada.
It's my pleasure to greet you this morning
to begin a conversation about smoking and stroke,
with an emphasis on the best practices for your patients.
0:17
It's important to understand that of all of
the clinical interventions that can be delivered from a preventive perspective,
nothing is as powerful in any clinical setting as smoking cessation.
0:29
Unfortunately, when we address smoking cessation
we have to confront a variety of outmoded misconceptions,
prejudicial attitudes, and frank misunderstandings about the basis of smoking,
smoking behavior, and approaches to smoking cessation.
I term these "the zombie concepts";
concepts which are difficult to kill off
and which get in the way of our being able to
effectively help those of our patients who are smokers.
0:56
Although stroke is sometimes referred to as a cerebrovascular accident, it's no accident.
Approximately, 75 percent of all strokes
can be attributed to an adverse risk factor profile.
1:09
It's also important to recognize that it's been suggested that it's difficult to
identify any other condition that represents such a mixture of lethality,
prevalence, and neglect as does tobacco addiction.
All of them are ironic,
given that we have an array of
effective and readily available interventions in the 21st century.
1:31
So, as far as stroke is concerned,
there's a very strong relationship between
cigarette smoking and ischemic stroke risk in young women.
Spousal smoking poses a very important stroke risk for never-smokers and former smokers.
We know that current or recent smokers experience
poorer stroke outcomes than do nonsmokers three months after an acute ischemic event.
We know that in people who have experienced a stroke,
they have doubled the risk of mortality compared to
non-smokers and ex-smokers in exactly the same clinical state.